BSE Live
Oct 01, 16:01Prev. Close
190.90
Open Price
190.85
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:59Prev. Close
191.16
Open Price
191.07
Bid Price (Qty.)
199.04 (311)
Offer Price (Qty.)
0.00 (0)
Profit & Loss account of Piramal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 13 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 5,202.56 | 4,325.31 | 3,349.59 | 2,977.57 | 2,899.75 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 5,202.56 | 4,325.31 | 3,349.59 | 2,977.57 | 2,899.75 | |
Total Operating Revenues | 5,285.71 | 4,390.11 | 3,443.22 | 3,094.95 | 2,938.81 | |
Other Income | 207.35 | 202.06 | 341.07 | 223.59 | 197.97 | |
Total Revenue | 5,493.06 | 4,592.17 | 3,784.29 | 3,318.54 | 3,136.78 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 1,596.93 | 1,545.55 | 1,166.48 | 1,003.68 | 986.70 | |
Purchase Of Stock-In Trade | 733.60 | 624.91 | 548.69 | 509.70 | 183.21 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -84.57 | -61.62 | 53.31 | -30.17 | 57.86 | |
Employee Benefit Expenses | 736.19 | 613.93 | 548.50 | 425.30 | 395.15 | |
Finance Costs | 114.56 | 107.10 | 115.87 | 53.55 | 4.71 | |
Depreciation And Amortisation Expenses | 222.09 | 205.26 | 192.08 | 130.64 | 143.64 | |
Other Expenses | 1,263.12 | 1,049.42 | 1,028.71 | 789.14 | 696.96 | |
Total Expenses | 4,581.92 | 4,084.55 | 3,653.64 | 2,881.84 | 2,468.23 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 911.14 | 507.62 | 130.65 | 436.70 | 668.55 | |
Exceptional Items | 0.00 | 0.00 | -6.96 | -12.47 | 18.23 | |
Profit/Loss Before Tax | 911.14 | 507.62 | 123.69 | 424.23 | 686.78 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 199.44 | 112.48 | 38.77 | 96.34 | 104.98 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 20.30 | 3.92 | 15.42 | -15.16 | 10.30 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 219.74 | 116.40 | 54.19 | 81.18 | 115.28 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 691.40 | 391.22 | 69.50 | 343.05 | 571.50 | |
Profit/Loss From Continuing Operations | 691.40 | 391.22 | 69.50 | 343.05 | 571.50 | |
Profit/Loss For The Period | 691.40 | 391.22 | 69.50 | 343.05 | 571.50 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 5.22 | 3.05 | 0.58 | 2.91 | 9.11 | |
Diluted EPS (Rs.) | 5.20 | 3.05 | 0.58 | 2.91 | 9.11 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 14.47 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
31.07.2025
30.07.2025
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y
14.07.2025
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y
19.05.2025
Piramal Pharma Standalone March 2025 Net Sales at Rs 1,689.80 crore, up 10.78% Y-o-Y
14.05.2025
Piramal Pharma Standalone March 2025 Net Sales at Rs 1,689.80 crore, up 10.78% Y-o-Y
14.05.2025
Piramal Pharma Consolidated March 2025 Net Sales at Rs 2,754.07 crore, up 7.9% Y-o-Y